Prophylactic correction of the international normalized ratio in neurosurgery: A brief review of a brief literature a review

Journal of Neurosurgery

Volumn 114, Issue 1, 2011, Pages 9-18

  West, Kelly L ^a   Adamson, Cory ^a,b   Hoffman, Maureane ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Coagulation; Fresh frozen plasma; Neurosurgery; Prothrombin time international normalized ratio; Transfusion

Indexed keywords

BLOOD CLOTTING FACTOR; FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN K GROUP;

ALLERGIC REACTION; ANAPHYLAXIS; BLEEDING; BLOOD CLOTTING; CLINICAL PRACTICE; GOOD CLINICAL PRACTICE; HEMODYNAMICS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG INJURY; NEUROSURGERY; PARTIAL THROMBOPLASTIN TIME; PLASMA TRANSFUSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN TIME; REVIEW;

BLOOD TRANSFUSION; FACTOR VIIA; HEMOSTASIS, SURGICAL; HUMANS; INTERNATIONAL NORMALIZED RATIO; NEUROSURGICAL PROCEDURES; PARTIAL THROMBOPLASTIN TIME; PLASMA; PROTHROMBIN TIME; RECOMBINANT PROTEINS;

EID: 78651278366     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.7.JNS091857     Document Type: Review

References (67)

1. Abdel-Wahab OI, Healy B, Dzik WH: Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 46:1279-1285, 2006 (Pubitemid 44117952)
2. Aguilar MI, Hart RG, Kase CS, Freeman WD, Hoeben BJ, García RC, et al: Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc 82:82-92, 2007
3. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies: Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 105:198-208, 2006
4. Anonymous: A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. Ann Neurol 42:857-865, 1997
5. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E: The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (3 Suppl):204S-233S, 2004 [Erratum in Transfusion 127:415-416, 2005]
6. Asaf T, Reuveni H, Yermiahu T, Leiberman A, Gurman G, Porat A, et al: The need for routine pre-operative coagulation screening tests (prothrombin time PT/partial thromboplastin time PTT) for healthy children undergoing elective tonsillectomy and/or adenoidectomy. Int J Pediatr Otorhinolaryngol 61:217-222, 2001
7. Brody DL, Aiyagari V, Shackleford AM, Diringer MN: Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage. Neurocrit Care 2:263-267, 2005
8. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF: Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 245:812-818, 2007
9. Center for Biologics Evaluation and Research: Fatalities Reported to FDA Following Blood Collection and Transfusion. Annual Summary for Fiscal Year 2008. (http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/ TransfusionDonationFatalities/ucm113649.htm) [Accessed July 27, 2010]
10. Chowdhury P, Saayman AG, Paulus U, Findlay GP, Collins PW: Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 125:69-73, 2004 (Pubitemid 38453280)
11. Ciavarella D, Reed RL, Counts RB, Baron L, Pavlin E, Heimbach DM, et al: Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol 67:365-368, 1987 (Pubitemid 18022356)
12. Corwin HL: Anemia and red blood cell transfusion in the critically ill. Semin Dial 19:513-516, 2006 (Pubitemid 44736558)
13. Dara SI, Rana R, Afessa B, Moore SB, Gajic O: Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy. Crit Care Med 33:2667-2671, 2005 (Pubitemid 41682123)
14. Davis JW, Davis IC, Bennink LD, Hysell SE, Curtis BV, Kaups KL, et al: Placement of intracranial pressure monitors: are "normal" coagulation parameters necessary? J Trauma 57:1173-1177, 2004
15. Deitcher SR: Interpretation of the international normalised ratio in patients with liver disease. Lancet 359:47-48, 2002 (Pubitemid 34119199)
16. Deveras RA, Kessler CM: Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med 137:884-888, 2002
17. Eisenberg JM, Clarke JR, Sussman SA: Prothrombin and partial thromboplastin times as preoperative screening tests. Arch Surg 117:48-51, 1982 (Pubitemid 12198127)
18. Etemadrezaie H, Baharvahdat H, Shariati Z, Lari SM, Shakeri MT, Ganjeifar B: The effect of fresh frozen plasma in severe closed head injury. Clin Neurol Neurosurg 109:166-171, 2007
19. Flaherty ML, Kissela B, Woo D, Kleindorfer D, Alwell K, Sekar P, et al: The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 68:116-121, 2007
20. Fleck RA, Rao LV, Rapaport SI, Varki N: Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 59:421-437, 1990
21. Frazee LA, Bourguet CC, Gutierrez W, Elder-Arrington J, Elackattu AE, Haller NA: Retrospective evaluation of a method to predict fresh-frozen plasma dosage in anticoagulated patients. Am J Ther 15:111-118, 2008
22. Gajic O, Dzik WH, Toy P: Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm? Crit Care Med 34 (5 Suppl):S170-S173, 2006 (Pubitemid 43670485)
23. Goldstein JN, Thomas SH, Frontiero V, Joseph A, Engel C, Snider R, et al: Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke 37:151-155, 2006
24. Harhangi BS, Kompanje EJ, Leebeek FW, Maas AI: Coagulation disorders after traumatic brain injury. Acta Neurochir (Wien) 150:165-175, 2008
25. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409-417, 1999
26. Hedner U: Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000. Semin Thromb Hemost 26:363-366, 2000
27. Hoffman M: Laboratory monitoring of high-dose factor VIIa therapy. Ann Intern Med 139:791, 2003
28. Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, et al: Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 62:307-310, 2007
29. Holland LL, Brooks JP: Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol 126:133-139, 2006
30. Ingerslev J, Vanek T, Culic S: Use of recombinant factor VIIa for emergency reversal of anticoagulation. J Postgrad Med 53:17-22, 2007 (Pubitemid 46197703)
31. Jansen JO, Thomas R, Loudon MA, Brooks A: Damage control resuscitation for patients with major trauma. BMJ 338:b1778, 2009
32. Kamal AH, Tefferi A, Pruthi RK: How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc 82:864-873, 2007
33. Keeling D: International Normalized Ratio in patients not on vitamin K antagonists. J Thromb Haemost 5:188-189, 2007
34. Kessler CM: Urgent reversal of warfarin with prothrombin complex concentrate: where are the evidence-based data? J Thromb Haemost 4:963-966, 2006
35. Kitchens CS: To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost 3:2607-2611, 2005
36. Lacroix J, Hébert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, et al: Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 356:1609-1619, 2007
37. Lankiewicz MW, Hays J, Friedman KD, Tinkoff G, Blatt PM: Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost 4:967-970, 2006
38. Le Roux C, Lejus C, Surbleb M, Renaudin M, Guillaud C, de Windt A, et al: Is haemostasis biological screening always useful before performing a neuraxial blockade in children? Paediatr Anaesth 12:118-123, 2002
39. Lee SB, Manno EM, Layton KF, Wijdicks EF: Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP. Neurology 67:1272-1274, 2006
40. MacLennan S, Williamson LM: Risks of fresh frozen plasma and platelets. J Trauma 60 (6 Suppl):S46-S50, 2006
41. Martini WZ, Cortez DS, Dubick MA, Park MS, Holcomb JB: Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. J Trauma 65:535-543, 2008
42. Massicotte L, Beaulieu D, Thibeault L, Roy JD, Marleau D, Lapointe R, et al: Coagulation defects do not predict blood product requirements during liver transplantation. Transplantation 85:956-962, 2008
43. May AK, Young JS, Butler K, Bassam D, Brady W: Coagulopathy in severe closed head injury: is empiric therapy warranted? Am Surg 63:233-236, 1997
44. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al: Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 358:2127-2137, 2008
45. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352:777-785, 2005
46. Mayer SA, Davis SM, Skolnick BE, Brun NC, Begtrup K, Broderick JP, et al: Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke 40:833-840, 2009
47. Monroe DM, Hoffman M, Oliver JA, Roberts HR: Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 99:542-547, 1997 (Pubitemid 27519853)
48. Monroe DM III, Hoffman M, Roberts HR: Molecular Biology and Biochemistry of the Coagulation Factors and Pathways of Blood Coagulation, in Kaushansky K, Lichtman MA, Beutler E, et al (eds): William's Hematology, ed 8. New York: McGraw-Hill, 2010, pp 1815-1843
49. Norda R, Tynell E, Akerblom O: Cumulative risks of early fresh frozen plasma, cryoprecipitate and platelet transfusion in Europe. J Trauma 60 (6 Suppl):S41-S45, 2006
50. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, et al: Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 126:11-28, 2004
51. Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, et al: Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 348:423-428, 1996
52. Popovsky MA: Pulmonary consequences of transfusion: TRALI and TACO. Transfus Apheresis Sci 34:243-244, 2006
53. Sarani B, Dunkman WJ, Dean L, Sonnad S, Rohrbach JI, Gracias VH: Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 36:1114-1118, 2008
54. Schramm B, Leslie K, Myles PS, Hogan CJ: Coagulation studies in preoperative neurosurgical patients. Anaesth Intensive Care 29:388-392, 2001
55. Segal JB, Dzik WH: Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 45:1413-1425, 2005
56. Shaz BH, Dente CJ, Harris RS, MacLeod JB, Hillyer CD: Transfusion management of trauma patients. Anesth Analg 108:1760-1768, 2009
57. Siddiq F, Jalil A, McDaniel C, Brock DG, Pineda CC, Bell RD, et al: Effectiveness of Factor IX complex concentrate in reversing warfarin associated coagulopathy for intracerebral hemorrhage. Neurocrit Care 8:36-41, 2008
58. Stainsby D, Jones H, Asher D, Atterbury C, Boncinelli A, Brant L, et al: Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 20:273-282, 2006
59. Stanworth SJ: The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology (Am Soc Hematol Educ Program) 2007:179-186, 2007
60. Stone TJ, Riesenman PJ, Charles AG: Red blood cell transfusion within the first 24 hours of admission is associated with increased mortality in the pediatric trauma population: a retrospective cohort study. J Trauma Manag Outcomes 2:9, 2008
61. Talving P, Benfield R, Hadjizacharia P, Inaba K, Chan LS, Demetriades D: Coagulopathy in severe traumatic brain injury: a prospective study. J Trauma 66:55-61, 2009
62. Tripodi A, Caldwell SH, Hoffman M, Trotter JF, Sanyal AJ: Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease. Aliment Pharmacol Ther 26:141-148, 2007 (Pubitemid 46985499)
63. Vigué B: Bench-to-bedside review: optimising emergency reversal of vitamin K antagonists in severe haemorrhage - from theory to practice. Crit Care 13:209, 2009
64. Wallis JP, Dzik S: Is fresh frozen plasma overtransfused in the United States? Transfusion 44:1674-1675, 2004
65. Williamson LM, Cardigan R, Prowse CV: Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety? Transfusion 43:1322-1329, 2003
66. Zehtabchi S, Nishijima DK: Impact of transfusion of freshfrozen plasma and packed red blood cells in a 1:1 ratio on survival of emergency department patients with severe trauma. Acad Emerg Med 16:371-378, 2009
67. Zehtabchi S, Soghoian S, Liu Y, Carmody K, Shah L, Whittaker B, et al: The association of coagulopathy and traumatic brain injury in patients with isolated head injury. Resuscitation 76:52-56, 2008